Tousif, S., Singh, D. K., Mukherjee, S., Ahmad, S., Arya, R., Nanda, R., . . . Das, G. (2017). Nanoparticle-Formulated Curcumin Prevents Posttherapeutic Disease Reactivation and Reinfection with Mycobacterium tuberculosis following Isoniazid Therapy. Front Immunol.
シカゴスタイル引用形Tousif, Sultan, et al. "Nanoparticle-Formulated Curcumin Prevents Posttherapeutic Disease Reactivation and Reinfection With Mycobacterium Tuberculosis Following Isoniazid Therapy." Front Immunol 2017.
MLA引用形式Tousif, Sultan, et al. "Nanoparticle-Formulated Curcumin Prevents Posttherapeutic Disease Reactivation and Reinfection With Mycobacterium Tuberculosis Following Isoniazid Therapy." Front Immunol 2017.
警告: この引用は必ずしも正確ではありません.